Cancer Control

癌症控制

基本信息

项目摘要

CANCER CONTROL PROGRAM: SUMMARY The Cancer Control (CC) Program fosters population sciences research that seeks to reduce cancer morbidity and mortality in South Carolina while providing novel, evidence-based cancer control interventions that can be applied beyond the state’s borders. Guided by two cross-cutting themes, cancer disparities and tobacco control, CC members have made marked progress in all areas. To address cancer health disparities, CC members es- tablished a precision medicine center to dissect and address the complex genetic, psychological, and social fac- tors impacting cancer disparities, established systems to increase the accrual of minority patients to clinical trials, and identified advanced glycation endproducts as a pharmacological target for a phase 2 trial in African Ameri- can cancer patients of low socioeconomic status. Advances in tobacco control include identification of neu- rocognitive mechanisms that increase smoking relapse risk, development of pharmacological strategies for smoking cessation, and implementation of an inpatient stop smoking service that reduces hospital readmissions. Co-led by Chanita Hughes-Halbert, PhD and Matthew J. Carpenter, PhD, national leaders in minority health and cancer disparities and tobacco control, respectively, the program comprises 25 population health and phy- sician-scientist faculty members from nine departments. Excluding career development and training grants, the annual total direct peer-reviewed funding base for the program is $4.4M, an increase of 37.5% since the prior renewal, with $1.6M from the NCI, $2.1M from other NIH awards, and $0.6M from other peer-reviewed sources. CC members foster collaborative research and lead several new large center awards and cooperative grants, including an NCI P01, NCI UG1, NCI U54, and an NIMHD U54. Through well-established training pipe- lines, members invest in mentoring and, as a result, six junior faculty hold peer-reviewed career development awards. During the past five years, CC members authored 183 cancer-relevant publications, of which 83% were collaborative with Hollings Cancer Center members in CC and other research programs. The exceptional quality of the program’s research is reflected by transformative insights into the causes of cancer disparities, discovery of molecular and behavioral risk factors underlying cancer susceptibility, and evaluation of evidence- based approaches to encourage tobacco cessation. These have been published in top-tier journals such as Lancet, Lancet Oncol, N Engl J Med, J Med Genet, Am J Respir and Crit Care Med, JAMA Psychiatry, J Clin Oncol, and Nat Genet. CC members launched innovative trial interventions in the areas of care delivery, pre- vention, supportive care, improved diagnostics, and survivorship, with 842 individuals enrolled in interventional studies in 2017. With continued strong faculty recruitment, mentoring of emerging independent scientists, and development of transdisciplinary team-based interprogrammatic initiatives, the CC Program is exceptionally well equipped to lead efforts in reducing the cancer burden in South Carolina.
癌症控制计划:摘要 癌症控制(CC)计划促进了旨在减少癌症发病率的人群科学研究 南卡罗来纳州的死亡率以及提供新颖的,循证的癌症控制干预措施 超越州边界。在两个横切主题,癌症分布和烟草控制的指导下, CC成员在所有领域都取得了明显的进展。为了解决癌症健康分布,CC成员ES- 提出了一个精确的医学中心,以剖析和解决复杂的遗传,心理和社会方面 影响癌症差异的TOR,建立的系统以提高少数族裔患者对临床试验的准确性, 并确定高级糖基化最终产物是非洲ameri-的2期试验的药物靶标 社会经济状况低下的癌症患者。烟草控制的进展包括识别neu- 增加吸烟救济风险的Rocognity机制,制定药物的策略 戒烟,并实施住院的停止吸烟服务,以减少医院的再入院。 由Chanita Hughes-Halbert博士和Matthew J. Carpenter博士共同领导,少数民族健康领导人 该计划分别包括25种人口健康和PHY- 来自九个部门的西西亚语科学家教师。不包括职业发展和培训补助金, 该计划的年度直接直接同行评审基础为440万美元,自之前的增长37.5% 续签,来自NCI的160万美元,来自其他NIH奖的210万美元,其他同行评审的60万美元 来源。 CC成员培养合作研究,并领导几个新的大型中心奖与合作 赠款,包括NCI P01,NCI UG1,NCI U54和NIMHD U54。通过公认的训练管 - 台词,成员投资于心理,结果,六个初级教师持有同行评审职业发展 奖项。在过去的五年中,CC成员撰写了183个与癌症相关的出版物,其中83% 与CC和其他研究计划中的Hollings癌症中心成员合作。异常 该计划研究的质量反映了对癌症分布原因的变革性见解, 发现癌症易感性的分子和行为危险因素的发现,并评估证据 - 基于鼓励烟草戒烟的方法。这些已发表在顶级期刊上,例如 柳叶刀,柳叶刀Oncol,N Engl J Med,J Med Genet,AM J呼吸和Crit Care Med,Jama Psychiatry,J Clin Oncol和Nat Genet。 CC成员在护理提供领域启动了创新的试验干预措施, 发表,支持护理,改善诊断和生存,有842个人参加介入 2017年的研究。随着持续强大的教职招聘,新兴独立科学家的心理和 开发基于跨学科团队的解释性倡议,CC计划是异常的 能够在减少南卡罗来纳州的癌症伯恩(Cancer Burnen)方面进行努力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew J Carpenter其他文献

Response to: Clinical trial shows that giving smokers free e-cigarettes creates more dual users than switchers or quitters
回应:临床试验表明,向吸烟者提供免费电子烟比转换者或戒烟者创造更多的双重使用者
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
    Matthew J Carpenter;K. M. Cummings;Tracy T. Smith
  • 通讯作者:
    Tracy T. Smith
Selling smoking cessation
推销戒烟
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. M. Cummings;Matthew J Carpenter
  • 通讯作者:
    Matthew J Carpenter

Matthew J Carpenter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew J Carpenter', 18)}}的其他基金

A clinical trial of adaptive treatment for early smoking cessation relapse
早期戒烟复发适应性治疗的临床试验
  • 批准号:
    10752773
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment Dissemination
伐尼克兰取样促进戒烟和可扩展治疗传播的转化随机临床试验
  • 批准号:
    10455439
  • 财政年份:
    2020
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment Dissemination
伐尼克兰取样促进戒烟和可扩展治疗传播的转化随机临床试验
  • 批准号:
    10212989
  • 财政年份:
    2020
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment Dissemination
伐尼克兰取样促进戒烟和可扩展治疗传播的转化随机临床试验
  • 批准号:
    10669624
  • 财政年份:
    2020
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
关于电子烟吸食及其后果的自然主义全国随机研究
  • 批准号:
    9753192
  • 财政年份:
    2017
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
关于电子烟吸食及其后果的自然主义全国随机研究
  • 批准号:
    9976470
  • 财政年份:
    2017
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
关于电子烟吸食及其后果的自然主义全国随机研究
  • 批准号:
    10220890
  • 财政年份:
    2017
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Randomized Trial of E-cigarettes: Natural Uptake, Patterns, and Impact of Use
电子烟的随机试验:自然吸收、模式和使用的影响
  • 批准号:
    8683480
  • 财政年份:
    2014
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Novel Trial of Smokeless Tobacco for Cessation Induction in Unmotivated Smokers
无烟烟草对无动机吸烟者诱导戒烟的新试验
  • 批准号:
    8634739
  • 财政年份:
    2011
  • 资助金额:
    $ 5.06万
  • 项目类别:
A Novel Trial of Smokeless Tobacco for Cessation Induction in Unmotivated Smokers
无烟烟草对无动机吸烟者诱导戒烟的新试验
  • 批准号:
    8023918
  • 财政年份:
    2011
  • 资助金额:
    $ 5.06万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Research Education Core
研究教育核心
  • 批准号:
    10911633
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
  • 批准号:
    10911646
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Role of serum advanced glycation end-products in altering tendon properties with diabetes
血清晚期糖基化终末产物在改变糖尿病肌腱特性中的作用
  • 批准号:
    10737036
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Dissecting connections between diet, the microbiome and Alzheimers disease
剖析饮食、微生物组和阿尔茨海默病之间的联系
  • 批准号:
    10740056
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Research Education Core
研究教育核心
  • 批准号:
    10911647
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了